Challenges to Adolescent HPV Vaccination and Implementation of Evidence-Based Interventions to Promote Vaccine Uptake During the COVID-19 Pandemic: "HPV Is Probably Not at the Top of Our List"

Grace Ryan, Paul A Gilbert, Sato Ashida, Mary E Charlton, Aaron Scherer, Natoshia M Askelson, Grace Ryan, Paul A Gilbert, Sato Ashida, Mary E Charlton, Aaron Scherer, Natoshia M Askelson

Abstract

Introduction: The COVID-19 pandemic has prevented many adolescents from receiving their vaccines, including the human papillomavirus (HPV) vaccine, on time. However, little is known about the impact of the pandemic on implementation of clinic-level evidence-based interventions (EBIs) that help to improve HPV vaccine uptake. In this qualitative study, we explored the pandemic's impact on EBI implementation and HPV vaccine delivery.

Methods: During August-November 2020, we interviewed clinic managers in a rural, midwestern state about their experiences implementing EBIs for HPV vaccination during the COVID-19 pandemic. We used a multipronged sampling approach with both stratified and purposive sampling to recruit participants from Vaccines for Children clinics. We then conducted a thematic analysis of transcripts.

Results: In interviews (N = 18), 2 primary themes emerged: decreased opportunities for HPV vaccination and disruption to HPV-related implementation work. Most participants reported decreases in opportunities to vaccinate caused by structural changes in how they delivered care (eg, switched to telehealth visits) and patient fear of exposure to COVID-19. Disruptions to EBI implementation were primarily due to logistical challenges (eg, decreases in staffing) and shifting priorities.

Conclusion: During the pandemic, clinics struggled to provide routine care, and as a result, many adolescents missed HPV vaccinations. To ensure these adolescents do not fall behind on this vaccine series, providers and researchers will need to recommit to EBI implementation and use existing strategies to promote vaccination. In the long term, improvements are needed to make EBI implementation more resilient to ensure that progress does not come to a halt in future pandemic events.

References

    1. Bramer CA, Kimmins LM, Swanson R, Kuo J, Vranesich P, Jacques-Carroll LA, et al. Decline in child vaccination coverage during the COVID-19 pandemic — Michigan Care Improvement Registry, May 2016–May 2020. MMWR Morb Mortal Wkly Rep 2020;69(20):630–1. 10.15585/mmwr.mm6920e1
    1. Santoli JM, Lindley MC, DeSilva MB, Kharbanda EO, Daley MF, Galloway L, et al. Effects of the COVID-19 pandemic on routine pediatric vaccine ordering and administration — United States, 2020. MMWR Morb Mortal Wkly Rep 2020;69(19):591–3. 10.15585/mmwr.mm6919e2
    1. Elam-Evans LD, Yankey D, Singleton JA, Sterrett N, Markowitz LE, Williams CL, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years — United States, 2019. MMWR Morb Mortal Wkly Rep 2020;69(33):1109–16. 10.15585/mmwr.mm6933a1
    1. Daniels V, Saxena K, Roberts C, Kothari S, Corman S, Yao L, et al. Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: a model based analysis. Vaccine 2021;39(20):2731–5. 10.1016/j.vaccine.2021.04.003
    1. Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination — updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2016;65(49):1405–8. 10.15585/mmwr.mm6549a5
    1. St Sauver JL, Rutten LJF, Ebbert JO, Jacobson DJ, McGree ME, Jacobson RM. Younger age at initiation of the human papillomavirus (HPV) vaccination series is associated with higher rates of on-time completion. Prev Med 2016;89:327–33. 10.1016/j.ypmed.2016.02.039
    1. Palmer T, Wallace L, Pollock KG, Cuschieri K, Robertson C, Kavanagh K, et al. Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12–13 in Scotland: retrospective population study. BMJ 2019;365:l1161. 10.1136/bmj.l1161
    1. Racey CS, Albert A, Donken R, Smith L, Spinelli JJ, Pedersen H, et al. Cervical intraepithelial neoplasia rates in British Columbia women: a population-level data linkage evaluation of the school-based HPV immunization program. J Infect Dis 2020;221(1):81–90. 10.1093/infdis/jiz422
    1. Askelson NM, Ryan G, Seegmiller L, Pieper F, Kintigh B, Callaghan D. Implementation challenges and opportunities related to HPV vaccination quality improvement in primary care clinics in a rural state. J Community Health 2019;44(4):790–5. 10.1007/s10900-019-00676-z
    1. Perkins RB, Zisblatt L, Legler A, Trucks E, Hanchate A, Gorin SS. Effectiveness of a provider-focused intervention to improve HPV vaccination rates in boys and girls. Vaccine 2015;33(9):1223–9. 10.1080/21645515.2019.1602433
    1. Calo WA, Shah PD, Gilkey MB, Vanderpool RC, Barden S, Doucette WR, et al. Implementing pharmacy-located HPV vaccination: findings from pilot projects in five U.S. states. Hum Vaccin Immunother 2019;15(7-8):1831–8. 10.1080/21645515.2019.1602433
    1. CFIR Research Team. CFIR guide. . Updated 2019. Accessed August 30, 2021.
    1. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006;3(2):77–101. 10.1191/1478088706qp063oa
    1. Escoffery C, Riehman K, Watson L, Priess AS, Borne MF, Halpin SN, et al. Facilitators and barriers to the implementation of the HPV VACs (Vaccinate Adolescents against Cancers) Program: a consolidated framework for implementation research analysis. Prev Chronic Dis 2019;16:E85. 10.5888/pcd16.180406
    1. Centers for Medicare & Medicaid Services. Fact sheet: service use among Medicaid & CHIP beneficiaries age 18 and under during COVID-19. Published September 23, 2020. . Accessed November 23, 2021.
    1. Gilkey MB, Bednarczyk RA, Gerend MA, Kornides ML, Perkins RB, Saslow D, et al. Getting human papillomavirus vaccination back on track: protecting our national investment in human papillomavirus vaccination in the COVID-19 era. J Adolesc Health 2020;67(5):633–4. 10.1016/j.jadohealth.2020.08.013
    1. Cataldi JR, Kerns ME, O’Leary ST. Evidence-based strategies to increase vaccination uptake: a review. Curr Opin Pediatr 2020;32(1):151–9. 10.1097/MOP.0000000000000843
    1. Abdullahi LH, Kagina BM, Ndze VN, Hussey GD, Wiysonge CS. Improving vaccination uptake among adolescents. Cochrane Database Syst Rev 2020;1(1):CD011895.
    1. Chambers DA. Considering the intersection between implementation science and COVID-19. Implement Res Pract 2020;1:1–4. 10.1177/0020764020925994
    1. Wensing M, Sales A, Armstrong R, Wilson P. Implementation science in times of COVID-19. Implement Sci 2020;15(1):42. 10.1186/s13012-020-01006-x
    1. Hailemariam M, Bustos T, Montgomery B, Barajas R, Evans LB, Drahota A. Evidence-based intervention sustainability strategies: a systematic review. Implement Sci 2019;14(1):57. 10.1186/s13012-019-0910-6
    1. Moore JE, Mascarenhas A, Bain J, Straus SE. Developing a comprehensive definition of sustainability. Implement Sci 2017;12(1):110. 10.1186/s13012-017-0637-1

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner